All Stories

  1. Comparing quality of life in smell and taste disorders with other chronic conditions – a narrative review
  2. Investigating the Effect of Tumour Necrosis Factor Antagonist on Olfaction
  3. A Cross‐Sectional Study Exploring Patient Experiences, Unmet Needs and Desired Support in Those With Olfactory Dysfunction
  4. A Prospective Cohort Study Investigating the Role of a Screening Smell and Taste Test in Patients Following Head Injury
  5. The APOLLO Trial: A P roof-of-Concept Study for Vitamin A Nasal Drops in COVID-19 Related Post-Infectious Ol factory Dysfunction
  6. Digital intervention for smell training: a real-world study on engagement, adherence, and behavioural dynamics
  7. Investigating idiopathic anosmia as a prodromal state of Parkinson’s disease
  8. The need to promote smell health across the globe
  9. Endoscopic Management of Sinus Neoplasia: An Experience of a Dedicated Sinus Centre in Image-Guided Surgery of Inverted Papillomata
  10. A trial comparing sinus surgery and antibiotics in adults with chronic rhinosinusitis
  11. The need to promote smell health across the globe
  12. Exploring barriers to seeking support for Smell and Taste Disorders (SATDs) amongst minority communities in the UK
  13. Gustatory dysfunction in dementia and cognitive decline
  14. Olfactory loss and dysfunction in dementia and cognitive decline
  15. A New Approach to Dementia
  16. \fancyhead [R] Smell and Taste Disorder Impact on Eating Habits: a cross-sectional observational study
  17. The Development and Validation of the Smell‐Qx Questionnaire, Based on a Systematic Review of the Literature and the COMET Initiative on the Development of Core Outcome Sets for Clinical Trials in Olfactory Disorders
  18. Epidemiology of Cholesteatoma in the UK Biobank
  19. British Skull Base Society Consensus on Vestibular Schwannoma Surveillance
  20. Nasal endoscopy score thresholds to trigger consideration of chronic rhinosinusitis treatment escalation and implications for disease control
  21. Epidemiology of Cholesteatoma in the UK Biobank
  22. Smell Above All: Envisioning Smell-Centred Future Worlds
  23. Impact of olfactory disorders on personal safety and well-being: a cross-sectional observational study
  24. Evaluation of Hyperbaric Oxygen Therapy as an Adjuvant Treatment for Necrotising Otitis Externa: Retrospective, observational, case-control study.
  25. The Clinical Course of Paranasal Sinus Mucocoeles—A Retrospective Case Series
  26. Obesity and Olfaction
  27. Abstracts from the 56th European Society of Human Genetics (ESHG) Conference: Hybrid Posters
  28. International clinical assessment of smell: An international, cross‐sectional survey of current practice in the assessment of olfaction
  29. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
  30. Delivery of Topical Drugs to the Olfactory Cleft
  31. Endoscopic management of sinus neoplasia: case series of image-guided surgery of inverted papillomata and recommended best practice for managing cases.
  32. Everything smells like poo, landfill, and rotten food”: A retrospective case report using Clinical Emotional Freedom Techniques (EFT) for parosmia following COVID-19
  33. A double-blinded randomised controlled trial of vitamin A drops to treat post-viral olfactory loss: study protocol for a proof-of-concept study for vitamin A nasal drops in post-viral olfactory loss (APOLLO)
  34. Position paper on olfactory dysfunction: 2023
  35. Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study
  36. Prevalence and Associated Factors of Medication Non-Adherence in CRS Patients following Endoscopic Sinus Surgery
  37. Understanding the Impact of Chronic Rhinosinusitis with Nasal Polyposis on Smell and Taste: An International Patient Experience Survey
  38. Assessment of COVID-19-related olfactory dysfunction and its association with psychological, neuropsychiatric, and cognitive symptoms
  39. Exploring Endotypes in Chronic Rhinosinusitis (ExpRess): Protocol for a cohort study
  40. Systematic Review of Protein Biomarkers in Adult Patients With Chronic Rhinosinusitis
  41. Impact of olfactory disorders on personal safety & wellbeing: a cross-sectional observational study
  42. Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiative
  43. Nose Gym: An Interactive Smell Training Solution
  44. Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination
  45. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  46. Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial
  47. Commentary on Patient Advocacy and Research Priorities in Olfactory and Gustatory Disorders
  48. Olfactory Disorders Questionnaire: Scaling severity of quality‐of‐life impact
  49. The Nose and the Effects of SARS-CoV-2 Pandemic
  50. The growing burden of long COVID in the United Kingdom: Insights from the UK Coronavirus Infection Survey
  51. The EUFOREA pocket guide for chronic rhinosinusitis
  52. High prevalence of persistent smell loss and qualitative smell dysfunction during the coronavirus disease 2019 (COVID‐19) pandemic in the United States: Urgent need for clinical trials
  53. Investigations and Outcomes for Olfactory Disorders
  54. Manipulation under anaesthesia of fractured nasal bones – a 10-year retrospective study
  55. The burden of olfactory dysfunction during the COVID-19 pandemic in the United Kingdom
  56. Ask the Experts: An International Consensus on Managing Post-Infectious Olfactory Dysfunction Including COVID-19
  57. Establishing UK research priorities in smell and taste disorders: A James Lind alliance priority setting partnership
  58. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  59. The use of MRI in a tertiary smell and taste clinic: Lessons learned based on a retrospective analysis
  60. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis
  61. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  62. The COVANOS trial – insight into post-COVID olfactory dysfunction and the role of smell training
  63. When is Magnetic Resonance Imaging most beneficial in olfactory dysfunction? A retrospective review of a tertiary referral smell and taste clinic
  64. Establishing UK Research Priorities In Smell and Taste Disorders: A James Lind Alliance Priority Setting Partnership
  65. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss
  66. International consensus statement on allergy and rhinology: Olfaction
  67. Effects of fluid and drinking on pneumonia mortality in older adults: A systematic review and meta-analysis
  68. Interventions for the treatment of persistent post-viral olfactory dysfunction
  69. Observational retrospective study calculating health service costs of patients receiving surgery for chronic rhinosinusitis in England, using linked patient-level primary and secondary care electronic data
  70. Olfaction and CSF Leak
  71. 918 Nasal Packing Duration in The Management of Epistaxis: A Cohort Study
  72. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  73. Cultural Adaptation and Validity of the Sniffin’ Sticks Psychophysical Test for the UK Setting
  74. Barriers to effective health care for patients who have smell or taste disorders
  75. Patient perspectives about participation in a chronic rhinosinusitis trial during the COVID pandemic: a qualitative study.
  76. Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction
  77. British Rhinological Society Consensus Guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps
  78. Socioeconomic, comorbidity, lifestyle, and quality of life comparisons between chronic rhinosinusitis phenotypes
  79. Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view
  80. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  81. International consensus statement on allergy and rhinology: rhinosinusitis 2021
  82. Barriers to Effective Healthcare for Patients Who Have Smell or Taste Disorders
  83. British Rhinological Society Consensus Guidance on the use of biological therapies for Chronic Rhinosinusitis with Nasal Polyps
  84. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  85. Admission avoidance in acute epistaxis: A prospective national audit during the initial peak of the COVID‐19 pandemic
  86. Health-Related Quality of Life Impairment Among Patients With Severe Chronic Rhinosinusitis With Nasal Polyps in the SINUS-24 Trial
  87. Evaluation of Smoking as a Modifying Factor in Chronic Rhinosinusitis
  88. Paediatric tonsillectomy in England: A cohort study of clinical practice and outcomes using Hospital Episode Statistics data (2008‐2019)
  89. Maximising recruitment to a randomised controlled trial for chronic rhinosinusitis using qualitative research methods: the MACRO conversation study
  90. A systematic review to examine the relationship between objective and patient‐reported outcome measures in sinonasal disorders: recommendations for use in research and clinical practice
  91. Qualitative Olfactory Disorders: Patient Experiences and Self-Management
  92. Corrigendum to: More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  93. Patient Experiences of Postinfectious Olfactory Dysfunction
  94. Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory Symptoms
  95. Course of symptoms for loss of sense of smell and taste over time in one thousand forty‐one healthcare workers during the Covid‐19 pandemic: Our experience
  96. Admission avoidance in tonsillitis and peritonsillar abscess: A prospective national audit during the initial peak of the COVID‐19 pandemic
  97. Comparison of COVID-19 and common cold chemosensory dysfunction
  98. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training
  99. Socioeconomic, comorbidity, lifestyle and quality of life comparisons between chronic rhinosinusitis phenotypes: Data from the National Chronic Rhinosinusitis Epidemiology Study
  100. Patient Experiences of Post-Infectious Olfactory Dysfunction
  101. Management of new onset loss of sense of smell during the COVID‐19 pandemic ‐ BRS Consensus Guidelines
  102. Is loss of sense of smell a diagnostic marker in COVID‐19: A systematic review and meta‐analysis
  103. Smoking as a modifying factor in chronic rhinosinusitis: Data from the Chronic Rhinosinusitis Epidemiology Study
  104. Olfactory Loss of Function as a Possible Symptom of COVID-19
  105. Defining appropriateness criteria for endoscopic sinus surgery in the management of adult dental implant patients with incidental maxillary sinus findings on conebeam computed tomography
  106. Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection
  107. The best COVID-19 predictor is recent smell loss: a cross-sectional study
  108. Barriers to accessing healthcare in patients with olfactory and gustatory disorders
  109. Qualitative Olfactory Disorders: Patient experiences and self-management
  110. More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  111. Management of new onset anosmia during the COVID pandemic - BRS Consensus Guidelines
  112. Parosmia is associated with relevant olfactory recovery after olfactory training
  113. The impact of patients losing their sense of smell
  114. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers – A systematic review of the literature, case series, and recommendations for clinical assessment and management
  115. Cholesteatoma and family history: An international survey
  116. The Socioeconomic Cost of Chronic Rhinosinusitis Study
  117. Biologics for chronic rhinosinusitis
  118. European Position Paper on Rhinosinusitis and Nasal Polyps 2020
  119. Biologics for chronic rhinosinusitis
  120. An unmet need: Patients with smell and taste disorders
  121. 139 Risk of parkinson’s in idiopathic anosmia
  122. Lacrimal sac primary squamous cell carcinoma with synchronous tonsillar primary squamous cell carcinoma
  123. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
  124. Antibiotic usage in chronic rhinosinusitis: analysis of national primary care electronic health records
  125. Optimising trial outcomes and patient retention for the MACRO trial for chronic rhinosinusitis
  126. The genetics of cholesteatoma study. Loss‐of‐function variants in an affected family
  127. What is the most appropriate treatment for chronic rhinosinusitis?
  128. Validation of the olfactory disorders questionnaire for English‐speaking patients with olfactory disorders
  129. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  130. Exploring the association between ingestion of foods with higher potential salicylate content and symptom exacerbation in chronic rhinosinusitis. Data from the National Chronic Rhinosinusitis Epidemiology Study
  131. Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial
  132. Expert panel process to optimise the design of a randomised controlled trial in chronic rhinosinusitis (the MACRO programme)
  133. Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care
  134. Unilateral visual loss resulting from orbital encroachment of an ethmoidal juvenile trabecular ossifying fibroma
  135. Risk of mortality and cardiovascular events following macrolide prescription in chronic rhinosinusitis patients: a cohort study using linked primary care electronic health records
  136. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  137. Wooden spatula sinusitis following maxillary expansion surgery
  138. Management strategies for chronic rhinosinusitis: a qualitative study of GP and ENT specialist views of current practice in the UK
  139. Topical and systemic antifungal therapy for chronic rhinosinusitis
  140. Development of an International Odor Identification Test for Children: The Universal Sniff Test
  141. Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study
  142. Saline irrigation for allergic rhinitis
  143. Faculty of 1000 evaluation for Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review.
  144. Eustachian tube symptoms are frequent in chronic rhinosinusitis and respond well to endoscopic sinus surgery
  145. Endonasal Approaches to Maxillary Sinus
  146. The use of nasal sprays and rinses in patients with chronic sinus disease
  147. The British Rhinological Society multidisciplinary consensus recommendations on the hospital management of epistaxis
  148. Initial assessment in the management of adult epistaxis: systematic review
  149. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  150. Health care usage and quality of life reporting in chronic sinusitis patients
  151. The genetics of cholesteatoma. A systematic review using narrative synthesis
  152. Position paper on olfactory dysfunction
  153. Chronic rhinosinusitis and mood disturbance
  154. A randomised controlled trial of sodium citrate spray for non-conductive olfactory disorders
  155. Saline irrigation for allergic rhinitis
  156. Cochrane Corner: Extracts from The Cochrane Library: Intranasal Steroids for Chronic Rhinosinusitis
  157. CHronic Rhinosinusitis Outcome MEasures (CHROME), developing a core outcome set for trials of interventions in chronic rhinosinusitis
  158. Position paper on olfactory dysfunction
  159. Chronic rhinosinusitis and mood disturbance
  160. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  161. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  162. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  163. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  164. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  165. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  166. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  167. Topical and systemic antifungal therapy for chronic rhinosinusitis
  168. The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis
  169. SNOT-22 in a control population
  170. Current practice in septal surgery and adjunctive turbinate reduction - A multisite experience in 226 consecutive cases
  171. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  172. Genetics of Cholesteatoma Project
  173. Short-course oral steroids alone for chronic rhinosinusitis
  174. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  175. Different types of intranasal steroids for chronic rhinosinusitis
  176. Systemic and topical antibiotics for chronic rhinosinusitis
  177. Saline irrigation for chronic rhinosinusitis
  178. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  179. Chronic rhinosinusitis and mood disturbance
  180. Long term quality of life in patients with fungal sinus disease
  181. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  182. Chronic rhinosinusitis: patient experiences of primary and secondary care - a qualitative study
  183. Anatomic findings in revision endoscopic sinus surgery: Case series and review of contributory factors
  184. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  185. Systemic and topical antibiotics for chronic rhinosinusitis
  186. Saline irrigation for chronic rhinosinusitis
  187. Different types of intranasal steroids for chronic rhinosinusitis
  188. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  189. Short-course oral steroids alone for chronic rhinosinusitis
  190. Abstracts of the 2015 Annual Meeting 4-6 September 2015 Telford International Centre UK
  191. The impact of commissioning for rhinosinusitis in England
  192. Investigation of nasal diseases
  193. British Rhinological Society 14th Annual Meeting The Central Convention Centre, Manchester. 15th May 2015
  194. The burden of revision sinonasal surgery in the UK--data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study
  195. Authors’ response
  196. Hyposmia
  197. Assessing the sense of smell
  198. Cost-Effective Surgical Intervention in Chronic Rhinosinusitis
  199. Bilateral glossopharyngeal nerve palsy following tonsillectomy: a very rare and difficult complication of a common procedure
  200. Managing chronic rhinosinusitis and respiratory disease: a qualitative study of triggers and interactions
  201. Getting involved in ENT clinical research in the UK; how can the NIHR Clinical Research Network help?
  202. The Impact of Olfactory Disorders in the United Kingdom
  203. Chronic Rhinosinusitis and Mood Disturbance
  204. Management of CRSwNPs Surgically
  205. Olfactory Improvement and Decline in Patients with Posttraumatic Olfactory Dysfunction
  206. SNOT-22 in a Control Population
  207. Anatomy and Physiology of the Olfactory and Gustatory Systems
  208. Cerebrospinal Fluid Rhinorrhoea
  209. Ciliary Motility Disorders
  210. Clinical Governance and Audit
  211. Complications of Sinusitis
  212. Endoscopic Sinus Surgery and Complications
  213. Epistaxis
  214. European Position Paper on Rhinosinusitis and Nasal Polyps
  215. Facial Flaps, Scars, and Keloids
  216. Facial Fractures and Swelling
  217. Fungal Sinus Disease
  218. Headache and Facial Pain
  219. Medical Statistics
  220. Microbiology of ENT
  221. Olfactory and Gustatory Disorders
  222. Sinonasal Anatomy and Physiology
  223. Tumours of the Nose and Paranasal Sinuses
  224. Retronasal testing of olfactory function: an investigation and comparison in seven countries
  225. Using a passive coordinate measurement arm for motion tracking of a rigid endoscope for augmented-reality image-guided surgery
  226. Unilateral cacosmia: a presentation of maxillary fungal infestation
  227. When mealtime is the most dreaded moment of your day
  228. Pneumatisation of turbinates and paranasal sinuses in children: case report
  229. A double-blinded randomised controlled trial of the effects of sodium citrate on olfactory thresholds
  230. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  231. Epistaxis Secondary to an Oncocytoma of the Anterior Skull Base
  232. Skull base oncocytoma presenting as epistaxis: an unusual presentation of a rare tumour successfully managed with active surveillance
  233. A useful tool - systematic checklist for evaluating sinus scans
  234. Validation study of the “Sniffin’ Sticks” olfactory test in a British population: a preliminary communication
  235. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  236. Allergic fungal rhinosinusitis - a new staging system
  237. Allergic fungal rhinosinusitis - a new staging system
  238. Olfactory Dysfunction in Allergic Fungal Rhinosinusitis
  239. Selecting the Best Approach to the Frontal Sinus
  240. Nanomedicine in otorhinolaryngology: what does the future hold?
  241. Endoscopic management of inverted papillomas: long-term results, the St. Pauls Sinus Centre experience
  242. Endoscopic frontal sinusotomy-Preventing recurrence or a route to revision?
  243. Tumefactive fibroinflammatory lesion of the frontal sinus
  244. The Leicester semi-automated olfactory threshold test--a psychophysical olfactory test for the 21st century
  245. SUBJECTS AND METHODS
  246. Periorbital oedema and surgical emphysema, an unusual complication of a dental procedure: a case report
  247. Proximal Lacrimal Obstruction – A Review
  248. The superosmic phenomenon
  249. The Leicester Olfactometer
  250. Does methicillin-resistantStaphylococcus aureushave a significant role in the peri-operative course of patients undergoing rhinological surgery?
  251. ENT cases seen at a local ‘walk-in centre’: a one year review
  252. Does hormone replacement therapy in post-menopausal women have any effect upon nasal physiology?
  253. A brief history of olfaction and olfactometry
  254. The superosmic phenomenon
  255. Olfactory clearance: what time is needed in clinical practice?
  256. The Effect of Female Hormone Manipulation on Nasal Physiology
  257. R142: The Effects of Sensory Deprivation on Olfactory Thresholds
  258. R152: Olfactory Adaptation and Clearance in Clinical Practice
  259. Bronchiectasis and sino-nasal disease: a review
  260. What is the short term effect of perfumes on olfactory thresholds?
  261. Which variables matter in smell tests in the clinic?
  262. Does the benefit of adenoidectomy in addition to ventilation tube insertion persist long-term?
  263. Methicillin resistant Staphylococcus aureus: is it a problem for nasal surgery?
  264. Randomised-controlled study comparing post-operative pain between coblation palatoplasty and laser palatoplasty
  265. Comparison of Subjective Perception with Objective Measurement of Olfaction
  266. Response to Rachmanidou
  267. A double‐blinded randomized controlled trial of coblation versus conventional dissection tonsillectomy on postoperative symptoms
  268. Timing of tracheostomy in adult patients: Potential ramifications are alarming
  269. Variability of vascularity in nasal mucosa as demonstrated by CD34 immunohistochemistry
  270. Do our Noses Lead Us Away from the Scent?
  271. Superosmia: A New Vomeronasal Organ Mediated Phenomenon?
  272. A double-blinded randomized controlled trial of coblation versus conventional dissection tonsillectomy on post- operative symptoms
  273. Is there a role for more day-case septal surgery?
  274. Erratum
  275. Canalicular adenoma of the parotid gland
  276. Paediatric retropharyngeal abscess
  277. Which solvent for olfactory testing?
  278. Nasal physiological changes during pregnancy
  279. The effect of the steroid sex hormones on the nasal airway during the normal menstrual cycle1
  280. The effect of temperature, humidity and peak inspiratory nasal flow on olfactory thresholds
  281. Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates
  282. Subjects and methods
  283. Hyposmia